60
Participants
Start Date
August 1, 2023
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2027
Pirfenidone Oral Tablet
Patients in the pirfenidone treatment arm will be given pirfenidone 267mg tablet, tid for 1 day followed by dose escalation to two 267 mg tablet tid for 6 days. Thus, the treatment will be for total of 7 days or till patients develop an adverse event that requires their participation in the study to be stopped.
Placebo
The placebo tablets will be an exact replica of the pirfenidone tablet.
RECRUITING
UAB, Birmingham
WITHDRAWN
Mayo Clinic, Rochester
Collaborators (1)
Mayo Clinic
OTHER
University of Alabama at Birmingham
OTHER